标题
The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
作者
关键词
-
出版物
Journal of Inflammation Research
Volume Volume 14, Issue -, Pages 5273-5290
出版商
Informa UK Limited
发表日期
2021-10-13
DOI
10.2147/jir.s334996
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Circulating proteins protect against renal decline and progression to end-stage renal disease in patients with diabetes
- (2021) Zaipul I. Md Dom et al. Science Translational Medicine
- Serum Endocrine Fibroblast Growth Factors as Potential Biomarkers for Chronic Kidney Disease and Various Metabolic Dysfunctions in Aged Patients
- (2020) Shogo Yamamoto et al. INTERNAL MEDICINE
- Innate immunity in diabetic kidney disease
- (2020) Sydney C. W. Tang et al. Nature Reviews Nephrology
- An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines
- (2020) Nicholas M. Selby et al. DIABETES OBESITY & METABOLISM
- The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy
- (2020) Ting-Ting Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective factors as biomarkers and targets for prevention and treatment of diabetic nephropathy: From current human evidence to future possibilities
- (2020) Natalia Nowak Journal of Diabetes Investigation
- Klotho/FGF23 and Wnt Signaling as Important Players in the Comorbidities Associated with Chronic Kidney Disease
- (2020) Juan Rafael Muñoz-Castañeda et al. Toxins
- Nephron Progenitor Maintenance Is Controlled through Fibroblast Growth Factors and Sprouty1 Interaction
- (2020) Sung-Ho Huh et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast Growth Factor 21 (FGF21) in Children and Adolescents With Chronic Kidney Disease
- (2020) Z GAMROT et al. PHYSIOLOGICAL RESEARCH
- Research Progress on the Pathological Mechanisms of Podocytes in Diabetic Nephropathy
- (2020) Lili Zhang et al. Journal of Diabetes Research
- Circular RNA Circ_0000064 promotes the proliferation and fibrosis of mesangial cells via miR-143 in diabetic nephropathy
- (2020) Xiaoxu Ge et al. GENE
- Activating AMP‐activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection from Nonalcoholic Fatty Liver Disease in Mice
- (2020) Qian Lin et al. HEPATOLOGY
- Klotho, Aging, and the Failing Kidney
- (2020) Sarah Buchanan et al. Frontiers in Endocrinology
- Mogroside IIIE Alleviates High Glucose-Induced Inflammation, Oxidative Stress and Apoptosis of Podocytes by the Activation of AMPK/SIRT1 Signaling Pathway
- (2020) Wei Xue et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Investigation of hub genes involved in diabetic nephropathy using biological informatics methods
- (2020) Zhanting Li et al. Annals of Translational Medicine
- circ_0037128/miR-17-3p/AKT3 axis promotes the development of diabetic nephropathy
- (2020) Qianqian Wang et al. GENE
- Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects
- (2020) Jae Min Cho et al. Scientific Reports
- FGF23, Biomarker or Target?
- (2019) Cristian Rodelo-Haad et al. Toxins
- Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
- (2019) Mitsuo Kato et al. Nature Reviews Nephrology
- Role of sirtuin-1 in diabetic nephropathy
- (2019) Wanning Wang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Dexmedetomidine ameliorates lipopolysaccharide‐induced acute kidney injury in rats by inhibiting inflammation and oxidative stress via the GSK‐3β/Nrf2 signaling pathway
- (2019) Xiujing Feng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PI3K/Akt-Nrf2 and Anti-Inflammation Effect of Macrolides in Chronic Obstructive Pulmonary Disease
- (2019) Xuejiao Sun et al. CURRENT DRUG METABOLISM
- Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Mexican Diabetic Patients and Its Association With Early Nephropathy
- (2019) Alfonso Farías-Basulto et al. ARCHIVES OF MEDICAL RESEARCH
- Renoprotective effects of brown adipose tissue activation in diabetic mice
- (2019) Ying‐Ying Cai et al. Journal of Diabetes
- Genetic Variants Flanking the FGF21 Gene Were Associated with Renal Function in Chinese Patients with Type 2 Diabetes
- (2019) Weihui Yu et al. Journal of Diabetes Research
- FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus
- (2019) Javier Donate-Correa et al. Journal of Clinical Medicine
- FGF1ΔHBS ameliorates chronic kidney disease via PI3K/AKT mediated suppression of oxidative stress and inflammation
- (2019) Dezhong Wang et al. Cell Death & Disease
- Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease
- (2019) Jeong Suk Kang et al. Scientific Reports
- Circ_0080425 inhibits cell proliferation and fibrosis in diabetic nephropathy via sponging miR‐24‐3p and targeting fibroblast growth factor 11
- (2019) Huifang Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- FGF23 and inflammation—a vicious coalition in CKD
- (2019) Brian Czaya et al. KIDNEY INTERNATIONAL
- Increased fibroblast growth factor-21 in chronic kidney disease is a trade-off between survival benefit and blood pressure dysregulation
- (2019) Toshihiro Nakano et al. Scientific Reports
- Fibroblast Growth Factor-1 Improves Insulin Resistance via Repression of JNK-Mediated Inflammation
- (2019) Lei Fan et al. Frontiers in Pharmacology
- Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes
- (2018) Carlo Bruno Giorda et al. ACTA DIABETOLOGICA
- Update on Diabetic Nephropathy: Core Curriculum 2018
- (2018) Kausik Umanath et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Fibroblast growth factor 19 protects the heart from oxidative stress-induced diabetic cardiomyopathy via activation of AMPK/Nrf2/HO-1 pathway
- (2018) Xin Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- FGF23C-tail improves diabetic nephropathy by attenuating renal fibrosis and inflammation
- (2018) Xiaomin Zhang et al. BMC BIOTECHNOLOGY
- TGF-β1/p53 signaling in renal fibrogenesis
- (2018) Stephen P. Higgins et al. CELLULAR SIGNALLING
- AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions
- (2018) Davoud Sanajou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Improving hyperglycemic effect of FGF-21 is associated with alleviating inflammatory state in diabetes
- (2018) Nan Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- FGF Family: From Drug Development to Clinical Application
- (2018) Qi Hui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ASK1 inhibitor treatment suppresses p38/JNK signalling with reduced kidney inflammation and fibrosis in rat crescentic glomerulonephritis
- (2018) Liv A. Amos et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism
- (2018) Guang Liang et al. KIDNEY INTERNATIONAL
- MRTF-A mediated FN and ICAM-1 expression in AGEs-induced rat glomerular mesangial cells via activating STAT5
- (2018) Qiuhong Chen et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Mitochondrial dysfunction in diabetic kidney disease
- (2018) Josephine M. Forbes et al. Nature Reviews Nephrology
- Klotho and endocrine fibroblast growth factors: marker of chronic kidney disease progression and cardiovascular complications?
- (2018) Makoto Kuro-o NEPHROLOGY DIALYSIS TRANSPLANTATION
- Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy
- (2018) Sonia Sifuentes-Franco et al. International Journal of Endocrinology
- Oxidative stress preconditioning of mouse perivascular myogenic progenitors selects a subpopulation of cells with a distinct survival advantage in vitro and in vivo
- (2018) Cesare Gargioli et al. Cell Death & Disease
- Inhibition of insulin resistance by PGE1 via autophagy-dependent FGF21 pathway in diabetic nephropathy
- (2018) Wei Wei et al. Scientific Reports
- Effect of hesperidin treatment on α-Klotho/FGF-23 pathway in rats with experimentally-induced diabetes
- (2018) Eda Dokumacioglu et al. BIOMEDICINE & PHARMACOTHERAPY
- Effect of FGF-21 on implant bone defects through hepatocyte growth factor (HGF)-mediated PI3K/AKT signaling pathway
- (2018) Shimao Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Reduction of cellular stress is essential for Fibroblast growth factor 1 treatment for diabetic nephropathy
- (2018) Yanqing Wu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Klotho proteins in health and disease
- (2018) Makoto Kuro-o Nature Reviews Nephrology
- Regulatory Mechanisms of the Wnt/β-Catenin Pathway in Diabetic Cutaneous Ulcers
- (2018) Han Zhang et al. Frontiers in Pharmacology
- Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease
- (2017) A. Esteghamati et al. IRISH JOURNAL OF MEDICAL SCIENCE
- Phyllanthus niruri leaves aqueous extract improves kidney functions, ameliorates kidney oxidative stress, inflammation, fibrosis and apoptosis and enhances kidney cell proliferation in adult male rats with diabetes mellitus
- (2017) Nelli Giribabu et al. JOURNAL OF ETHNOPHARMACOLOGY
- FGF1 — a new weapon to control type 2 diabetes mellitus
- (2017) Emanuel Gasser et al. Nature Reviews Endocrinology
- Non-genetic mechanisms of diabetic nephropathy
- (2017) Qiuxia Han et al. Frontiers of Medicine
- Inflammation regulates fibroblast growth factor 23 production
- (2016) Connor Francis et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Adipocyte STAT5 deficiency promotes adiposity and impairs lipid mobilisation in mice
- (2016) Doris Kaltenecker et al. DIABETOLOGIA
- Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update
- (2016) Niloy Bhattacharjee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Up-regulation of Nrf2 is involved in FGF21-mediated fenofibrate protection against type 1 diabetic nephropathy
- (2016) Yanli Cheng et al. FREE RADICAL BIOLOGY AND MEDICINE
- Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
- (2016) Valentin David et al. KIDNEY INTERNATIONAL
- Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
- (2016) Wing Yan So et al. MEDICINAL RESEARCH REVIEWS
- Roles of mTOR complexes in the kidney: implications for renal disease and transplantation
- (2016) Daniel Fantus et al. Nature Reviews Nephrology
- Trends in Chronic Kidney Disease in China
- (2016) Luxia Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms
- (2016) Luigi Gnudi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Therapeutics Targeting FGF Signaling Network in Human Diseases
- (2016) Masaru Katoh TRENDS IN PHARMACOLOGICAL SCIENCES
- TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription
- (2016) Yuki Kawarada et al. Scientific Reports
- Glypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney
- (2015) Koji Okamoto et al. AMERICAN JOURNAL OF PATHOLOGY
- ASK1 Inhibitor Halts Progression of Diabetic Nephropathy inNos3-Deficient Mice
- (2015) Greg H. Tesch et al. DIABETES
- FGF-21 alleviates diabetes-associated vascular complications: Inhibiting NF-κB/NLRP3 inflammasome-mediated inflammation?
- (2015) Mi-Hua Liu INTERNATIONAL JOURNAL OF CARDIOLOGY
- Circulating Fibroblast Growth Factor 21 Levels Predict Progressive Kidney Disease in Subjects With Type 2 Diabetes and Normoalbuminuria
- (2015) C. H. Lee et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of heparanase on renal fibrosis
- (2015) Valentina Masola et al. Journal of Translational Medicine
- Biomarkers of rapid chronic kidney disease progression in type 2 diabetes
- (2015) Helen C. Looker et al. KIDNEY INTERNATIONAL
- Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
- (2015) Chiara Degirolamo et al. NATURE REVIEWS DRUG DISCOVERY
- A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
- (2015) Wenting Xu et al. Cell Adhesion & Migration
- The Fibroblast Growth Factor signaling pathway
- (2015) David M. Ornitz et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Suppressor of cytokine signaling (SOCS) 2 attenuates renal lesions in rats with diabetic nephropathy
- (2014) Yuehong Zhou et al. ACTA HISTOCHEMICA
- Ramipril Lowers Plasma FGF-23 in Patients with Diabetic Nephropathy
- (2014) Mahmut Ilker Yilmaz et al. AMERICAN JOURNAL OF NEPHROLOGY
- FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability
- (2014) Neerupma Silswal et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity
- (2014) Valentina Masola et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Increase in AMPK brought about by cocoa is renoprotective in experimental diabetes mellitus by reducing NOX4/TGFβ-1 signaling
- (2014) Alexandros Papadimitriou et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer
- (2014) Jae Myoung Suh et al. NATURE
- Sulodexide and glycosaminoglycans in the progression of renal disease
- (2014) V. Masola et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease
- (2014) Rajiv Agarwal et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Essential role of PH domain and leucine-rich repeat protein phosphatase 2 in Nrf2 suppression via modulation of Akt/GSK3β/Fyn kinase axis during oxidative hepatocellular toxicity
- (2014) F Rizvi et al. Cell Death & Disease
- An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
- (2013) William L. Holland et al. Cell Metabolism
- Fibroblast Growth Factor 21 Improves Insulin Resistance and Ameliorates Renal Injury indb/dbMice
- (2013) H. W. Kim et al. ENDOCRINOLOGY
- ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
- (2013) Kehong Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3–5 chronic kidney disease patients
- (2013) Jocelyn S. Garland et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes
- (2013) Kazuhiro Hasegawa et al. NATURE MEDICINE
- Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease
- (2013) Annet Bouma-de Krijger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Mechanisms of Diabetic Complications
- (2013) Josephine M. Forbes et al. PHYSIOLOGICAL REVIEWS
- Renal Expression of FGF23 in Progressive Renal Disease of Diabetes and the Effect of Ace Inhibitor
- (2013) Cristina Zanchi et al. PLoS One
- Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation
- (2013) Chi Zhang et al. PLoS One
- Molecular Mechanisms of Fibroblast Growth Factor Signaling in Physiology and Pathology
- (2013) A. A. Belov et al. Cold Spring Harbor Perspectives in Biology
- Fibroblast growth factor 23
- (2013) Edward R Smith et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- FGF9 and FGF20 Maintain the Stemness of Nephron Progenitors in Mice and Man
- (2012) Hila Barak et al. DEVELOPMENTAL CELL
- Earlier Onset and Greater Severity of Disordered Mineral Metabolism in Diabetic Patients With Chronic Kidney Disease
- (2012) P. Wahl et al. DIABETES CARE
- MECHANISMS IN ENDOCRINOLOGY: Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21
- (2012) Pedro Iglesias et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Endocrine fibroblast growth factors 15/19 and 21: from feast to famine
- (2012) M. J. Potthoff et al. GENES & DEVELOPMENT
- A PPARγ–FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis
- (2012) Johan W. Jonker et al. NATURE
- Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine
- (2012) Kook Hwan Kim et al. NATURE MEDICINE
- The role of FGF23 in CKD—with or without Klotho
- (2012) Hirotaka Komaba et al. Nature Reviews Nephrology
- A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
- (2011) Yashpal S. Kanwar et al. Annual Review of Pathology-Mechanisms of Disease
- Growth Hormone Stimulates Transcription of the Fibroblast Growth Factor 21 Gene in the Liver through the Signal Transducer and Activator of Transcription 5
- (2011) Jie Yu et al. ENDOCRINOLOGY
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
- (2011) N. Itoh et al. JOURNAL OF BIOCHEMISTRY
- Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells
- (2011) Valentina Masola et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Association between serum fibroblast growth factor 21 and diabetic nephropathy
- (2011) Wei-Xia Jian et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese
- (2011) Zhuofeng Lin et al. PLoS One
- AMPK and SIRT1: a long-standing partnership?
- (2010) Neil B. Ruderman et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy
- (2010) S. M. Titan et al. Clinical Journal of the American Society of Nephrology
- Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK–SIRT1–PGC-1α pathway
- (2010) Mary D. L. Chau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of Fibroblast Growth Factor-10 during Both Inflammatory and Fibrotic Phases Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice
- (2009) Varsha V. Gupte et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Pathogenic perspectives for the role of inflammation in diabetic nephropathy
- (2009) Antonio Rivero et al. CLINICAL SCIENCE
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Pulsed Electromagnetic Fields Accelerate Normal and Diabetic Wound Healing by Increasing Endogenous FGF-2 Release
- (2009) Matthew J. Callaghan et al. PLASTIC AND RECONSTRUCTIVE SURGERY
- Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans
- (2008) X. Zhang et al. DIABETES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now